Capstone Therapeutics Corp (CAPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,183 | 8,123 | 9,201 | 10,205 | 11,355 |
| TOTAL | $7,266 | $8,320 | $9,506 | $10,588 | $11,685 |
| Non-Current Assets | |||||
| PPE Net | 5 | 7 | 13 | 23 | 28 |
| Intangibles | 862 | 902 | 941 | 980 | 1,019 |
| TOTAL | $867 | $909 | $954 | $1,003 | $1,047 |
| Total Assets | $8,133 | $9,229 | $10,460 | $11,591 | $12,732 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 200 | 74 | 313 | 233 | 209 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 1 |
| TOTAL | $206 | $101 | $334 | $294 | $214 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 193 | 282 | 191 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $206 | $101 | $334 | $294 | $214 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41 | 41 | 41 | 41 | 41 |
| Common Shares | 20 | 20 | 20 | 20 | 20 |
| Retained earnings | -181,303 | -180,101 | -179,092 | -178,097 | -177,157 |
| Other shareholders' equity | 0 | 0 | 0 | 193 | 477 |
| TOTAL | $7,927 | $9,128 | $10,126 | $11,297 | $12,518 |
| Total Liabilities And Equity | $8,133 | $9,229 | $10,460 | $11,591 | $12,732 |